BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 2950040)

  • 1. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
    Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
    Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic dose-response effects of i.v. verapamil in coronary artery disease.
    Silke B; Verma SP; Ahuja RC; Nelson GI; Hussain M; Taylor SH
    Herz; 1984 Dec; 9(6):353-61. PubMed ID: 6510876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
    Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
    Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
    Silke B; Verma SP; Hussain M; Jackson NC; Hafizullah M; Reynolds G; Taylor SH
    Herz; 1985 Apr; 10(2):112-9. PubMed ID: 3872835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
    Visser CA; Jaarsma W; Kan G; Lie KI
    Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
    Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
    Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease.
    Silke B; Frais MA; Muller P; Verma SP; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1985 Dec; 20(6):675-80. PubMed ID: 4091998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
    Silke B; Goldhammer E; Sharma SK; Verma SP; Taylor SH
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):457-63. PubMed ID: 2149514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    Postgrad Med J; 1991; 67 Suppl 5():S20-3. PubMed ID: 1839433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist.
    Vetrovec GW; Dailey S; Kay G; Epstein A; Plumb V
    Postgrad Med J; 1991; 67 Suppl 5():S60-1. PubMed ID: 1839444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischaemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial.
    Navarro Estrada J; Saglietti H; Dimarco M; Casabé H; Oliveri R
    Postgrad Med J; 1991; 67 Suppl 5():S52-3. PubMed ID: 1839441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of amlodipine in patients with severe coronary artery disease.
    Navarro Estrada JL; Oliveri R
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S24-8. PubMed ID: 7522284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
    Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
    Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
    Mauser M; Voelker W; Karsch KR
    Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.